Krebs, F. K., Trzeciak, E. R., Zimmer, S., Özistanbullu, D., Mitzel‐Rink, H., Meissner, M., . . . Tuettenberg, A. (2021). Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma. Cancer Med.

Krebs, Franziska K., Emily R. Trzeciak, Sophia Zimmer, Deniz Özistanbullu, Heidrun Mitzel‐Rink, Markus Meissner, Stephan Grabbe, Carmen Loquai, e Andrea Tuettenberg. "Immune Signature As Predictive Marker for Response to Checkpoint Inhibitor Immunotherapy and Overall Survival in Melanoma." Cancer Med 2021.

Krebs, Franziska K., et al. "Immune Signature As Predictive Marker for Response to Checkpoint Inhibitor Immunotherapy and Overall Survival in Melanoma." Cancer Med 2021.